The Global Oral Typhoid Vaccine Market, valued at USD 127.10 million in 2023, is projected to reach USD 363.95 million by 2032, growing at an impressive CAGR of 12.40% from 2024 to 2032, according to a new comprehensive analysis by Introspective Market Research. This robust expansion reflects a confluence of global public health imperatives: escalating typhoid burden in low-resource...